Ascendis Pharma A/S

(NASDAQ:ASND)

Latest On Ascendis Pharma A/S (ASND):

Date/Time Type Description Signal Details
2023-05-08 18:47 ESTNewsAscendis Pharma added to Wedbush's best ideas listN/A
2023-05-02 17:38 ESTNewsAscendis Pharma Q1 Earnings: Skytrofa Soars, PTH Hurdles Yet To ClearN/A
2023-05-01 17:06 ESTNewsAscendis' TransCon gets FDA rejection but company hopeful as no new trials requestedN/A
2023-04-28 02:05 ESTNewsAscendis Pharma A/S (ASND) Q1 2023 Earnings Call TranscriptN/A
2023-04-27 01:02 ESTNewsAscendis Pharma Q1 2023 Earnings PreviewN/A
2023-04-20 16:46 ESTNewsAscendis Pharma: A Promising Diversification PlayN/A
2023-04-17 01:29 ESTNewsAscendis Pharma: Recent FDA Setbacks Present A Buying OpportunityN/A
2023-04-06 23:12 ESTNewsAscendis Pharma: Is Dip On TransCon Application A Buy Opportunity?N/A
2023-04-03 14:24 ESTNewsAscendis stock slumps ~35% after FDA finds 'deficiencies' in TransCon applicationN/A
2023-04-03 14:24 ESTNewsAscendis downgraded at Credit Suisse on deficiencies in drug applicationN/A
2023-02-17 11:10 ESTNewsAscendis Pharma A/S (ASND) Q4 2022 Earnings Call TranscriptN/A
2023-02-16 22:05 ESTNewsAscendis Pharma GAAP EPS of -€10.40, revenue of €51.17MN/A
2023-02-15 19:21 ESTNewsAscendis Pharma FY 2022 Earnings PreviewN/A
2023-01-27 16:41 ESTNewsAscendis: Neutral On Skytrofa's Market Launch, Initiating With A Neutral RatingN/A
2023-01-19 02:12 ESTNewsAscendis Pharma: Group's Best Nearby Capital Gain Price-Position StockN/A
2022-11-17 14:37 ESTNewsAscendis, Visen' once-weekly growth hormone drug beats daily hGH in Chinese patients in trialN/A
2022-11-14 19:34 ESTNewsAscendis falls on Phase 2 data for achondroplasia candidateN/A
2022-11-05 05:43 ESTNewsAscendis Pharma A/S (ASND) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 12:46 ESTNewsAscendis Pharma: Translating Valuable IP Into A Profitable BusinessN/A
2022-11-03 02:59 ESTNewsAscendis Pharma GAAP EPS of -€3.03, revenue of €15.29MN/A
2022-11-01 19:43 ESTNewsAscendis Pharma Q3 2022 Earnings PreviewN/A
2022-11-01 03:36 ESTNewsAscendis parathyroid hormone therapy goes under FDA priority reviewN/A
2022-09-16 02:59 ESTNewsAscendis Pharma: TransCon CNP Data Coming Q4N/A
2022-08-31 23:18 ESTNewsAscendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTHN/A
2022-08-11 20:08 ESTNewsAscendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug SkytrofaN/A
2022-08-11 03:38 ESTNewsAscendis Pharma GAAP EPS of -€1.46 beats by €0.69, revenue of €6.16B beats by $6.15BN/A
2022-08-11 03:37 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 09:43 ESTNewsAscendis Pharma Q2 2022 Earnings PreviewN/A
2022-08-04 05:34 ESTNewsAscendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain ProspectN/A
2022-05-23 09:02 ESTNewsAscendis, Visen' TransCon hGH meets main goal in growth hormone deficiency China trial in childrenN/A
2022-05-13 04:45 ESTNewsAscendis Pharma slides after Street analysts cut price target over SKYTROFA revenue missN/A
2022-05-12 09:00 ESTNewsAscendis Pharma GAAP EPS of -€2.21 misses by €0.05, revenue of €6.83M beats by €1.98MN/A
2022-05-12 09:00 ESTNewsAscendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 19:27 ESTNewsAscendis Pharma Q1 2022 Earnings PreviewN/A
2022-05-09 22:24 ESTNewsAscendis Pharma: Biotech Bear Provides Attractive Entry PointN/A
2022-04-29 17:39 ESTNewsAscendis: Institutional Buying Activity Now Seen As Good Value By Market-MakersN/A
2022-03-25 08:03 ESTNewsAscendis Pharma prices $500.0M convertible senior notes offeringN/A
2022-03-23 22:32 ESTNewsAscendis Pharma slides on offering of $500M convertible senior notesN/A
2022-03-16 20:02 ESTNewsAscendis posts biggest intraday gain in six months as BofA upgrades on trial resultsN/A
2022-03-14 20:55 ESTNewsAscendis Pharma TransCon PTH for hypoparathyroidism meets main goal in phase 3 trialN/A
2022-03-03 04:55 ESTNewsAscendis Pharma GAAP EPS of $7.00 beats by €15.44, revenue of €7.77M misses by $0.13MN/A
2022-03-03 04:55 ESTNewsAscendis Pharma stock falls 7% despite Q4 bottom line beatN/A
2022-03-03 04:55 ESTNewsAscendis Pharma A/S' (ASND) CEO Jan Mikkelsen on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 18:03 ESTNewsAscendis Pharma FY Earnings PreviewN/A
2022-01-25 06:13 ESTNewsPfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunesN/A
2022-01-24 14:23 ESTNewsAscendis Pharma (ASND) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-24 14:23 ESTNewsPfizer/OPKO loss on somatragon could boost Ascendis Pharma's fortunesN/A
2022-01-14 01:12 ESTNewsAscendis Pharma's TransCon gets EU approval for growth hormone deficiency in childrenN/A
2021-12-30 05:41 ESTNewsAscendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-MakersN/A
2021-11-19 04:06 ESTNewsPhase 2 data shows durable response of Ascendis candidate for hypoparathyroidismN/A

About Ascendis Pharma A/S (ASND):

Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

See Advanced Chart

General

  • Name Ascendis Pharma A/S
  • Symbol ASND
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 482
  • Fiscal Year EndDecember
  • IPO Date2015-01-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.ascendispharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 917.83
  • Price/Book (Most Recent Quarter) 8.08
  • Enterprise Value Revenue 1052.08
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$8.67
  • Next Year EPS Estimate -$7.26
  • Next Quarter EPS Estimate -$2.01
  • Return on Assets -25%
  • Return on Equity -58%
  • Earnings Per Share -$5.09
  • Revenue Per Share $0
  • Gross Profit 6.95 million
  • Quarterly Earnings Growth -78.7%
View More

Highlights

  • Market Capitalization 7.87 billion
  • Analyst Target Price $194.63
  • Book Value Per Share $8.43
View More

Share Statistics

  • Shares Outstanding 53.75 million
  • Shares Float 43.76 million
  • % Held by Insiders 3%
  • % Held by Institutions 101.6%
  • Shares Short 2.48 million
  • Shares Short Prior Month 2.21 million
  • Short Ratio 11.66
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.79
  • 52 Week High $183.98
  • 52 Week Low $96.24
  • 50 Day Moving Average 152.16
  • 200 Day Moving Average 158.57
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Ascendis Pharma A/S (ASND) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Ascendis Pharma A/S (ASND) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$535000-$3.15-$1.87-68.17%
2020-09-302020-11-11$2.76 million-$2.72-$1.87-45.17%
2020-06-302020-08-27$1.44 million-$2.33-$1.61-44.68%
2020-03-312020-05-19$2.23 million-$1.44-$1.41-2.66%
2019-12-312019-12-31$2.51 million-$1.89-$1.62-16.67%
2019-09-302019-11-18$2.44 million-$0.59-$1.2954.34%
2019-06-302019-08-28$3.62 million-$1.38-$1.33-4.4%
2019-03-312019-05-30$6.07 million-$1.38-$1.14-20.89%
2018-12-312018-12-31$12.06 million-$0.86-$1.1424.56%
2018-09-302018-11-28$23153.51-$0.92-$1.1922.87%
2018-06-302018-08-29$20949.72-$0.64-$1.0035.45%
2018-03-312018-05-30$34444.58-$1.25-$0.88-41.8%
2017-12-312018-03-28$362000-$1.13-$0.99-14.12%
2017-09-302017-11-16$546000-$1.22-$0.86-42.4%
2017-06-302017-08-18$533000-$1.11-$0.88-26.09%
2017-03-312017-05-23$398000-$0.87-$0.76-15.03%
2016-12-312017-03-22$855000-$0.55-$0.7122.7%
2016-09-302016-11-30$1.36 million-$0.76-$0.64-19.56%
2016-06-302016-08-31$1.21 million-$0.59-$0.658.96%
2016-03-312016-04-14$1.43 million-$0.59-$0.30-95.13%
2015-09-302015-11-12$2.37 million-$0.29-$0.5648.21%
2015-06-302015-08-24$2.25 million-$0.63-$0.43-46.51%
2015-03-312015-05-18$2.24 million$0.07-$0.39117.95%
2014-12-312015-01-28$2.83 million-$0.65

Ascendis Pharma A/S (ASND) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Ascendis Pharma A/S (ASND) Chart:

Ascendis Pharma A/S (ASND) News:

Below you will find a list of latest news for Ascendis Pharma A/S (ASND) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Ascendis Pharma A/S (ASND) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-06-20500CALL0 0263.24TRUE00
2025-06-20550CALL0 0226.06TRUE00
2025-06-20600CALL0 0207.91TRUE00
2025-06-20650CALL0 0308.74TRUE00
2025-06-20700CALL0 1287.62TRUE00
2025-06-20750CALL0 1268.06TRUE00
2025-06-20800CALL0 0252.72TRUE00
2025-06-20850CALL0 0150.21TRUE00
2025-06-20900CALL0 0138.19TRUE00
2025-06-20950CALL0 092.94TRUE00
2025-06-201000CALL0 1189.33TRUE00
2025-06-201050CALL0 190.71TRUE00
2025-06-201100CALL0 680.43TRUE00
2025-06-201150CALL0 286.89TRUE00
2025-06-201200CALL0 385.74TRUE00
2025-06-201250CALL0 082.24TRUE00
2025-06-201300CALL0 971.16TRUE00
2025-06-2013529.35CALL0 570.45TRUE00
2025-06-2014024.95CALL0 20761.84TRUE00
2025-06-201450CALL0 863.34TRUE00
2025-06-2015016.8CALL0 661.78TRUE00
2025-06-2015521.7CALL0 1152.55TRUE00
2025-06-2016018.4CALL0 21952.21TRUE00
2025-06-2016515CALL1 6344.21TRUE10.07
2025-06-201708.45CALL0 1141.47TRUE00
2025-06-201757.2CALL0 3438.1FALSE00
2025-06-201804CALL36 101141.18FALSE-2.04-0.34
2025-06-201850CALL0 1043.44FALSE00
2025-06-201902.5CALL0 544.29FALSE00
2025-06-201950CALL0 149.41FALSE00
2025-06-202000CALL0 154.27FALSE00
2025-06-202100CALL0 265.09FALSE00
2025-06-202200CALL0 071.97FALSE00
2025-06-202300CALL0 881.65FALSE00
2025-06-202400CALL0 490.54FALSE00
2025-06-20500PUT0 0334.1FALSE00
2025-06-20550PUT0 0310.1FALSE00
2025-06-20600PUT0 2288.36FALSE00
2025-06-20650PUT0 2268.46FALSE00
2025-06-20700PUT0 1250.12FALSE00
2025-06-20750PUT0 0233.09FALSE00
2025-06-20800PUT0 0217.18FALSE00
2025-06-20850PUT0 0202.26FALSE00
2025-06-20900PUT0 0188.18FALSE00
2025-06-20950PUT0 5174.84FALSE00
2025-06-201000PUT0 0162.15FALSE00
2025-06-201050PUT0 0150.05FALSE00
2025-06-201100PUT0 1138.45FALSE00
2025-06-201150PUT0 30127.3FALSE00
2025-06-201200.2PUT0 974114.02FALSE00
2025-06-201250PUT0 50106.15FALSE00
2025-06-201300PUT0 2796.59FALSE00
2025-06-201351.72PUT0 788.64FALSE00
2025-06-201402.12PUT0 20780.96FALSE00
2025-06-201451.11PUT0 4268.37FALSE00
2025-06-201501PUT1 12356.61FALSE0.51
2025-06-201556PUT0 253.27FALSE00
2025-06-201601.93PUT0 439.64FALSE00
2025-06-201650PUT0 842.13FALSE00
2025-06-201700PUT0 20039.18FALSE00
2025-06-201755PUT75 032.28TRUE50
2025-06-201800PUT0 040.65TRUE00
2025-06-201850PUT0 035.34TRUE00
2025-06-201900PUT0 037.34TRUE00
2025-06-201950PUT0 033.33TRUE00
2025-06-202000PUT0 058.37TRUE00
2025-06-202100PUT0 26945.72TRUE00
2025-06-202200PUT0 055.02TRUE00
2025-06-202300PUT0 063.71TRUE00
2025-06-202400PUT0 071.88TRUE00
2025-07-18700CALL0 093.39TRUE00
2025-07-18750CALL0 065.4TRUE00
2025-07-18800CALL0 079.51TRUE00
2025-07-18850CALL0 085.76TRUE00
2025-07-18900CALL0 0135.37TRUE00
2025-07-18950CALL0 073.25TRUE00
2025-07-181000CALL0 064.96TRUE00
2025-07-181050CALL0 061.98TRUE00
2025-07-181100CALL0 061.56TRUE00
2025-07-181150CALL0 065.87TRUE00
2025-07-181200CALL0 059.45TRUE00
2025-07-181250CALL0 357.7TRUE00
2025-07-181300CALL0 055.01TRUE00
2025-07-181350CALL0 053.01TRUE00
2025-07-181400CALL0 12552.64TRUE00
2025-07-181450CALL0 048.79TRUE00
2025-07-181500CALL0 10047.34TRUE00
2025-07-181550CALL0 147.37TRUE00
2025-07-181600CALL0 246.59TRUE00
2025-07-1816519.5CALL10 3145.58TRUE19.50
2025-07-181706.3CALL0 35245.33TRUE00
2025-07-1817513.5CALL2 12343.61FALSE2.50.23
2025-07-181804.3CALL0 344.34FALSE00
2025-07-181859.5CALL1 143.01FALSE9.50
2025-07-181905.4CALL1 144.14FALSE5.40
2025-07-181951.95CALL0 042.83FALSE00
2025-07-182001.4CALL0 15142.33FALSE00
2025-07-182100CALL0 342.76FALSE00
2025-07-182200CALL0 146.8FALSE00
2025-07-182300.7CALL0 553.32FALSE00
2025-07-182400CALL0 358.25FALSE00
2025-07-18700PUT0 0154.2FALSE00
2025-07-18750PUT0 0143.73FALSE00
2025-07-18800PUT0 0133.96FALSE00
2025-07-18850PUT0 0124.78FALSE00
2025-07-18900PUT0 5116.13FALSE00
2025-07-18950PUT0 1108.45FALSE00
2025-07-181000PUT0 595.99FALSE00
2025-07-181050.2PUT0 29172.28FALSE00
2025-07-181100PUT0 086.85FALSE00
2025-07-181150PUT0 176.18FALSE00
2025-07-181200PUT0 070.55FALSE00
2025-07-181250PUT0 165.37FALSE00
2025-07-181300PUT0 160.51FALSE00
2025-07-181350PUT0 055.85FALSE00
2025-07-181400PUT0 20053.01FALSE00
2025-07-181450PUT0 049.1FALSE00
2025-07-181502.9PUT0 545.67FALSE00
2025-07-181553.55PUT0 445.07FALSE00
2025-07-181600PUT0 144.43FALSE00
2025-07-1816513.2PUT0 443.25FALSE00
2025-07-181700PUT0 042.15FALSE00
2025-07-181750PUT0 043.04TRUE00
2025-07-181800PUT0 042.13TRUE00
2025-07-181850PUT0 040.47TRUE00
2025-07-181900PUT0 040.22TRUE00
2025-07-181950PUT0 038.22TRUE00
2025-07-182000PUT0 037.25TRUE00
2025-07-182100PUT0 030.36TRUE00
2025-07-182200PUT0 038.69TRUE00
2025-07-182300PUT0 044.58TRUE00
2025-07-182400PUT0 050.12TRUE00
2025-09-19750CALL0 074.75TRUE00
2025-09-19800CALL0 058.31TRUE00
2025-09-19850CALL0 065.41TRUE00
2025-09-19900CALL0 054.6TRUE00
2025-09-19950CALL0 049.92TRUE00
2025-09-191000CALL0 049.48TRUE00
2025-09-191050CALL0 050.33TRUE00
2025-09-191100CALL0 049.63TRUE00
2025-09-191150CALL0 050.52TRUE00
2025-09-191200CALL0 050.92TRUE00
2025-09-191250CALL0 053.59TRUE00
2025-09-191300CALL0 052.32TRUE00
2025-09-191350CALL0 050.56TRUE00
2025-09-191400CALL0 049.05TRUE00
2025-09-191450CALL0 049.43TRUE00
2025-09-191500CALL0 150.38TRUE00
2025-09-191550CALL0 047.93TRUE00
2025-09-191600CALL0 048.29TRUE00
2025-09-191650CALL0 048.53TRUE00
2025-09-191700CALL0 047.44TRUE00
2025-09-191750CALL0 346.76FALSE00
2025-09-191800CALL0 245.92FALSE00
2025-09-1918514.85CALL0 146.77FALSE00
2025-09-191907CALL0 144.56FALSE00
2025-09-191950CALL0 045.29FALSE00
2025-09-192009.72CALL2 56847.45FALSE0.720.08
2025-09-192106.82CALL2 045.83FALSE6.820
2025-09-192200CALL0 041.99FALSE00
2025-09-192300CALL0 040.68FALSE00
2025-09-192400CALL0 50141.27FALSE00
2025-09-192500CALL0 042.37FALSE00
2025-09-19750PUT0 093.47FALSE00
2025-09-19800PUT0 087.16FALSE00
2025-09-19850PUT0 081.23FALSE00
2025-09-19900PUT0 076.01FALSE00
2025-09-19950PUT0 071.03FALSE00
2025-09-191000PUT0 066.27FALSE00
2025-09-191050PUT0 062.27FALSE00
2025-09-191100PUT0 058.61FALSE00
2025-09-191150PUT0 055.2FALSE00
2025-09-191200PUT0 051.56FALSE00
2025-09-191250PUT0 050.13FALSE00
2025-09-191300PUT0 046.97FALSE00
2025-09-191350PUT0 049.06FALSE00
2025-09-191400PUT0 049.07FALSE00
2025-09-191450PUT0 048.3FALSE00
2025-09-191500PUT0 048.67FALSE00
2025-09-191550PUT0 047.46FALSE00
2025-09-191600PUT0 046.63FALSE00
2025-09-191650PUT0 046.78FALSE00
2025-09-191700PUT0 046.27FALSE00
2025-09-191750PUT0 046.1TRUE00
2025-09-191800PUT0 045.33TRUE00
2025-09-191850PUT0 044.9TRUE00
2025-09-191900PUT0 043.88TRUE00
2025-09-191950PUT0 043.35TRUE00
2025-09-192000PUT0 042.19TRUE00
2025-09-192100PUT0 041.66TRUE00
2025-09-192200PUT0 039.2TRUE00
2025-09-192300PUT0 038.15TRUE00
2025-09-192400PUT0 038.66TRUE00
2025-09-192500PUT0 041.53TRUE00
2025-10-17750CALL0 052.65TRUE00
2025-10-17800CALL0 050.98TRUE00
2025-10-17850CALL0 048.87TRUE00
2025-10-17900CALL0 058.75TRUE00
2025-10-17950CALL0 050.7TRUE00
2025-10-171000CALL0 051.26TRUE00
2025-10-171050CALL0 049.21TRUE00
2025-10-171100CALL0 049.2TRUE00
2025-10-171150CALL0 049.97TRUE00
2025-10-171200CALL0 049.96TRUE00
2025-10-171250CALL0 050TRUE00
2025-10-171300CALL0 049.99TRUE00
2025-10-171350CALL0 048.46TRUE00
2025-10-171400CALL0 049.18TRUE00
2025-10-171450CALL0 048.46TRUE00
2025-10-171500CALL0 047.87TRUE00
2025-10-171550CALL0 048.06TRUE00
2025-10-171600CALL0 047.28TRUE00
2025-10-171650CALL0 047.19TRUE00
2025-10-1717019.84CALL0 146.36TRUE00
2025-10-171750CALL0 046.29FALSE00
2025-10-1718013.8CALL0 345.52FALSE00
2025-10-171850CALL0 145.73FALSE00
2025-10-171900CALL0 045.38FALSE00
2025-10-171950CALL0 043.53FALSE00
2025-10-172000CALL0 043.9FALSE00
2025-10-172100CALL0 043.78FALSE00
2025-10-172200CALL0 241.93FALSE00
2025-10-172300CALL0 241.58FALSE00
2025-10-172400CALL0 141.22FALSE00
2025-10-172500CALL0 040.73FALSE00
2025-10-17750PUT0 083.56FALSE00
2025-10-17800PUT0 077.94FALSE00
2025-10-17850PUT0 073FALSE00
2025-10-17900PUT0 068.32FALSE00
2025-10-17950PUT0 064.15FALSE00
2025-10-171000PUT0 060.41FALSE00
2025-10-171050PUT0 157FALSE00
2025-10-171100PUT0 154.05FALSE00
2025-10-171150PUT0 051.45FALSE00
2025-10-171200PUT0 049.23FALSE00
2025-10-171250PUT0 246.51FALSE00
2025-10-171300PUT0 248.38FALSE00
2025-10-171356PUT0 147.86FALSE00
2025-10-171400PUT0 047.33FALSE00
2025-10-171450PUT0 047.17FALSE00
2025-10-171500PUT0 046.88FALSE00
2025-10-171550PUT0 046.74FALSE00
2025-10-171600PUT0 046.05FALSE00
2025-10-171650PUT0 046.27FALSE00
2025-10-171700PUT0 045.71FALSE00
2025-10-171750PUT0 145.51TRUE00
2025-10-171800PUT0 044.94TRUE00
2025-10-171850PUT0 044.26TRUE00
2025-10-171900PUT0 043.82TRUE00
2025-10-171950PUT0 043.65TRUE00
2025-10-172000PUT0 043.01TRUE00
2025-10-172100PUT0 041.57TRUE00
2025-10-172200PUT0 040.19TRUE00
2025-10-172300PUT0 039.09TRUE00
2025-10-172400PUT0 036.04TRUE00
2025-10-172500PUT0 038.79TRUE00
2025-12-19600CALL0 059.37TRUE00
2025-12-19650CALL0 068TRUE00
2025-12-19700CALL0 057TRUE00
2025-12-19750CALL0 155.7TRUE00
2025-12-19800CALL0 054.99TRUE00
2025-12-19850CALL0 055.95TRUE00
2025-12-19900CALL0 055.02TRUE00
2025-12-19950CALL0 054.09TRUE00
2025-12-191000CALL0 053.49TRUE00
2025-12-191050CALL0 055.22TRUE00
2025-12-191100CALL0 054.73TRUE00
2025-12-191150CALL0 055.12TRUE00
2025-12-191200CALL0 053.87TRUE00
2025-12-191250CALL0 3853.42TRUE00
2025-12-191300CALL0 153.21TRUE00
2025-12-191350CALL0 152.72TRUE00
2025-12-191400CALL0 352.41TRUE00
2025-12-1914545.54CALL0 252.11TRUE00
2025-12-191500CALL0 251.21TRUE00
2025-12-191550CALL0 050.95TRUE00
2025-12-191600CALL0 6651TRUE00
2025-12-191650CALL0 050.4TRUE00
2025-12-191700CALL0 8149.81TRUE00
2025-12-191750CALL0 049.35FALSE00
2025-12-191800CALL0 1248.8FALSE00
2025-12-191850CALL0 1548.66FALSE00
2025-12-191900CALL0 148.15FALSE00
2025-12-191950CALL0 6047.66FALSE00
2025-12-192000CALL0 5547.12FALSE00
2025-12-192100CALL0 1046.97FALSE00
2025-12-192200CALL0 4545.77FALSE00
2025-12-192300CALL0 045.48FALSE00
2025-12-192400CALL0 244.82FALSE00
2025-12-192500CALL0 244.49FALSE00
2025-12-19600PUT0 085.75FALSE00
2025-12-19650PUT0 179.93FALSE00
2025-12-19700PUT0 074.9FALSE00
2025-12-19750PUT0 070.53FALSE00
2025-12-19800PUT0 2066.96FALSE00
2025-12-19850PUT0 162.74FALSE00
2025-12-19900PUT0 2159.23FALSE00
2025-12-19950PUT0 156.48FALSE00
2025-12-191000PUT0 154.48FALSE00
2025-12-191050PUT0 153.78FALSE00
2025-12-191100PUT0 153.28FALSE00
2025-12-191150PUT0 052.77FALSE00
2025-12-191200PUT0 254.71FALSE00
2025-12-191250PUT0 152.05FALSE00
2025-12-191300PUT0 151.66FALSE00
2025-12-191350PUT0 151.45FALSE00
2025-12-191400PUT0 050.68FALSE00
2025-12-191450PUT0 150.73FALSE00
2025-12-191500PUT0 050.73FALSE00
2025-12-191550PUT0 050.34FALSE00
2025-12-191600PUT0 049.72FALSE00
2025-12-191650PUT0 049.32FALSE00
2025-12-191700PUT0 048.81FALSE00
2025-12-191750PUT0 048.49TRUE00
2025-12-191800PUT0 047.97TRUE00
2025-12-191850PUT0 16447.54TRUE00
2025-12-191900PUT0 047.02TRUE00
2025-12-191950PUT0 046.79TRUE00
2025-12-192000PUT0 1646.18TRUE00
2025-12-192100PUT0 145.51TRUE00
2025-12-192200PUT0 244.31TRUE00
2025-12-192300PUT0 043.02TRUE00
2025-12-192400PUT0 142.99TRUE00
2025-12-192500PUT0 041.17TRUE00
2026-01-16750CALL0 059.52TRUE00
2026-01-16800CALL0 059.17TRUE00
2026-01-16850CALL0 057.59TRUE00
2026-01-16900CALL0 057.48TRUE00
2026-01-16950CALL0 056.68TRUE00
2026-01-161000CALL0 058.09TRUE00
2026-01-161050CALL0 057.28TRUE00
2026-01-161100CALL0 056.53TRUE00
2026-01-161150CALL0 056.21TRUE00
2026-01-161200CALL0 055.98TRUE00
2026-01-161250CALL0 055.03TRUE00
2026-01-161300CALL0 054.82TRUE00
2026-01-161350CALL0 054.25TRUE00
2026-01-161400CALL0 053.75TRUE00
2026-01-161450CALL0 052.95TRUE00
2026-01-161500CALL0 852TRUE00
2026-01-161550CALL0 052TRUE00
2026-01-1616027.35CALL0 450.55TRUE00
2026-01-1616524.85CALL0 2150.2TRUE00
2026-01-161700CALL0 749.88TRUE00
2026-01-161750CALL0 049.39FALSE00
2026-01-161800CALL0 549.12FALSE00
2026-01-161850CALL0 5048.88FALSE00
2026-01-161900CALL0 248.68FALSE00
2026-01-161950CALL0 048.34FALSE00
2026-01-162000CALL0 247.97FALSE00
2026-01-1621016.16CALL0 347.88FALSE00
2026-01-162200CALL0 047.48FALSE00
2026-01-162300CALL0 046.61FALSE00
2026-01-162400CALL0 146.04FALSE00
2026-01-162500CALL0 045.43FALSE00
2026-01-16750PUT0 067.38FALSE00
2026-01-16800PUT0 063.93FALSE00
2026-01-16850PUT0 060.83FALSE00
2026-01-16900PUT0 058.41FALSE00
2026-01-16950PUT0 057.5FALSE00
2026-01-161000PUT0 054.21FALSE00
2026-01-161050PUT0 054.07FALSE00
2026-01-161100PUT0 054.07FALSE00
2026-01-161150PUT0 055.1FALSE00
2026-01-161200PUT0 054.36FALSE00
2026-01-161250PUT0 053.77FALSE00
2026-01-161300PUT0 553.28FALSE00
2026-01-161350PUT0 2752.85FALSE00
2026-01-161400PUT0 1952.22FALSE00
2026-01-161450PUT0 1451.64FALSE00
2026-01-1615018.6PUT0 150.99FALSE00
2026-01-161550PUT0 050.28FALSE00
2026-01-161600PUT0 049.91FALSE00
2026-01-161650PUT0 1649.36FALSE00
2026-01-161700PUT0 048.83FALSE00
2026-01-161750PUT0 048.13TRUE00
2026-01-161800PUT0 048TRUE00
2026-01-161850PUT0 047.79TRUE00
2026-01-161900PUT0 047.51TRUE00
2026-01-161950PUT0 046.97TRUE00
2026-01-162000PUT0 046.74TRUE00
2026-01-162100PUT0 046.12TRUE00
2026-01-162200PUT0 045.3TRUE00
2026-01-162300PUT0 045.35TRUE00
2026-01-162400PUT0 043.92TRUE00
2026-01-162500PUT0 042.8TRUE00
2026-06-18800CALL0 062.15TRUE00
2026-06-18850CALL0 063.24TRUE00
2026-06-18900CALL0 062.44TRUE00
2026-06-18950CALL0 060.32TRUE00
2026-06-181000CALL0 060.93TRUE00
2026-06-181050CALL0 059.32TRUE00
2026-06-181100CALL0 059.92TRUE00
2026-06-181150CALL0 058.64TRUE00
2026-06-181200CALL0 057.94TRUE00
2026-06-181250CALL0 057.6TRUE00
2026-06-181300CALL0 057.05TRUE00
2026-06-181350CALL0 056.81TRUE00
2026-06-181400CALL0 1056.84TRUE00
2026-06-181450CALL0 056.12TRUE00
2026-06-181500CALL0 055.86TRUE00
2026-06-181550CALL0 055.77TRUE00
2026-06-1816049CALL0 255.11TRUE00
2026-06-181650CALL0 054.63TRUE00
2026-06-181700CALL0 054.55TRUE00
2026-06-181750CALL0 053.88FALSE00
2026-06-181800CALL0 053.82FALSE00
2026-06-181850CALL0 053.27FALSE00
2026-06-181900CALL0 052.96FALSE00
2026-06-181950CALL0 052.88FALSE00
2026-06-182000CALL0 052.34FALSE00
2026-06-182100CALL0 051.62FALSE00
2026-06-182200CALL0 051.19FALSE00
2026-06-182300CALL0 051.07FALSE00
2026-06-18800PUT0 059.93FALSE00
2026-06-18850PUT0 058.82FALSE00
2026-06-18900PUT0 058.74FALSE00
2026-06-18950PUT0 058.04FALSE00
2026-06-181000PUT0 057.82FALSE00
2026-06-181050PUT0 056.59FALSE00
2026-06-181100PUT0 057.13FALSE00
2026-06-181150PUT0 056.13FALSE00
2026-06-181200PUT0 055.68FALSE00
2026-06-181250PUT0 055FALSE00
2026-06-181300PUT0 255.16FALSE00
2026-06-181350PUT0 054.86FALSE00
2026-06-181400PUT0 054.36FALSE00
2026-06-181450PUT0 054.12FALSE00
2026-06-181500PUT0 053.7FALSE00
2026-06-181550PUT0 053.11FALSE00
2026-06-181600PUT0 053.16FALSE00
2026-06-181650PUT0 053.03FALSE00
2026-06-181700PUT0 052.74FALSE00
2026-06-181750PUT0 052.29TRUE00
2026-06-181800PUT0 051.7TRUE00
2026-06-181850PUT0 051.7TRUE00
2026-06-181900PUT0 050.84TRUE00
2026-06-181950PUT0 050.57TRUE00
2026-06-182000PUT0 050.51TRUE00
2026-06-182100PUT0 049.65TRUE00
2026-06-182200PUT0 048.95TRUE00
2026-06-182300PUT0 048.59TRUE00

Latest ASND Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$79.93
Jun 13, 2022 7:59 PM EST4$79.91
Jun 13, 2022 7:59 PM EST118$79.93
Jun 13, 2022 7:59 PM EST9$79.97
Jun 13, 2022 7:59 PM EST17$79.97

Ascendis Pharma A/S (ASND) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025519002847/0000080255-19-002847-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000008025520001284/0000080255-20-001284-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000031506620000822/0000315066-20-000822-index.htm
2019-03-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000203/0000947871-19-000203-index.htm
2019-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787119000594/0000947871-19-000594-index.htm
2020-03-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000185/0000947871-20-000185-index.htm
2020-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000446/0000947871-20-000446-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000094787120000511/0000947871-20-000511-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021751/0001104659-20-021751-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920021912/0001104659-20-021912-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000110465920103962/0001104659-20-103962-index.htm
2019-02-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519042416/0001193125-19-042416-index.htm
2019-03-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519059442/0001193125-19-059442-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519061604/0001193125-19-061604-index.htm
2019-03-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519062499/0001193125-19-062499-index.htm
2019-03-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519065750/0001193125-19-065750-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519069120/0001193125-19-069120-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519074983/0001193125-19-074983-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096618/0001193125-19-096618-index.htm
2019-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312519096759/0001193125-19-096759-index.htm
2019-04-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519105316/0001193125-19-105316-index.htm
2019-04-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519112380/0001193125-19-112380-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519133019/0001193125-19-133019-index.htm
2019-05-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519149447/0001193125-19-149447-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161327/0001193125-19-161327-index.htm
2019-05-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519161365/0001193125-19-161365-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519173846/0001193125-19-173846-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519175289/0001193125-19-175289-index.htm
2019-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519181943/0001193125-19-181943-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519187411/0001193125-19-187411-index.htm
2019-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519191873/0001193125-19-191873-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519196527/0001193125-19-196527-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519221217/0001193125-19-221217-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519232458/0001193125-19-232458-index.htm
2019-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519244911/0001193125-19-244911-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519255970/0001193125-19-255970-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519263919/0001193125-19-263919-index.htm
2019-10-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519265843/0001193125-19-265843-index.htm
2019-11-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519292336/0001193125-19-292336-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519293431/0001193125-19-293431-index.htm
2019-11-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519294735/0001193125-19-294735-index.htm
2019-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312519312728/0001193125-19-312728-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520002169/0001193125-20-002169-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520005786/0001193125-20-005786-index.htm
2020-01-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520008093/0001193125-20-008093-index.htm
2020-02-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520033240/0001193125-20-033240-index.htm
2020-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520071551/0001193125-20-071551-index.htm
2020-03-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520092940/0001193125-20-092940-index.htm
2020-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520094591/0001193125-20-094591-index.htm
2020-04-0320-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520096870/0001193125-20-096870-index.htm
2020-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520108208/0001193125-20-108208-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520111593/0001193125-20-111593-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520112279/0001193125-20-112279-index.htm
2020-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520126717/0001193125-20-126717-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520133706/0001193125-20-133706-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520142982/0001193125-20-142982-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520146167/0001193125-20-146167-index.htm
2020-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520157336/0001193125-20-157336-index.htm
2020-06-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520167815/0001193125-20-167815-index.htm
2020-06-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520180048/0001193125-20-180048-index.htm
2020-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520185199/0001193125-20-185199-index.htm
2020-07-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187456/0001193125-20-187456-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520187810/0001193125-20-187810-index.htm
2020-07-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1612042/000119312520190428/0001193125-20-190428-index.htm
2020-07-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520191149/0001193125-20-191149-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520194325/0001193125-20-194325-index.htm
2020-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520219118/0001193125-20-219118-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520233148/0001193125-20-233148-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520241091/0001193125-20-241091-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520243078/0001193125-20-243078-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520252366/0001193125-20-252366-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257235/0001193125-20-257235-index.htm
2020-09-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520257292/0001193125-20-257292-index.htm
2020-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520263856/0001193125-20-263856-index.htm
2020-10-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1612042/000119312520265872/0001193125-20-265872-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520270385/0001193125-20-270385-index.htm
2020-10-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1612042/000119312520275018/0001193125-20-275018-index.htm
2019-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1612042/000121390019020915/0001213900-19-020915-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999719000498/9999999997-19-000498-index.htm
2020-07-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1612042/999999999720004106/9999999997-20-004106-index.htm